Preview

 Пульмонология

Расширенный поиск

Фенотип бронхиальной астмы с ожирением

https://doi.org/10.18093/0869-0189-2012-0-2-102-107

Полный текст:

Аннотация

Фенотип бронхиальной астмы с ожирением.

Об авторах

В. Н. Минеев
Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова
Россия

д. м. н. проф. кафедры госпитальной терапии им. акад. М.В.Черноруцкого 

197022, Санкт-Петербург, ул. Льва Толстого, 6 / 8. Тел.: (812) 450-71-63.



Т. М. Лалаева
Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова
Россия

к. м. н., очный докторант кафедры госпитальной терапии им. акад. М.В.Черноруцкого

197022, Санкт-Петербург, ул. Льва Толстого, 6 / 8. Тел.: (812) 234-24-75.



Т. С. Васильева
Поликлиника № 32; Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова
Россия

заочный аспирант кафедры госпитальной терапии им. акад. М.В.Черноруцкого 

197022, Санкт-Петербург, Вяземский пер., 3

197022, Санкт-Петербург, ул. Льва Толстого, 6 / 8. Тел.: (812) 234-24-75.



В. И. Трофимов
Санкт-Петербургский государственный медицинский университет им. акад. И.П.Павлова
Россия

проф., д. м. н., зав. кафедрой госпитальной терапии им. акад. М.В.Черноруцкого

197022, Санкт-Петербург, ул. Льва Толстого, 6 / 8. Тел.: (812) 234-24-54.



Список литературы

1. Федосеев Г.Б. Частная аллергология. СПб.: Нордмед-Издат; 2001; т. 2.

2. Федосеев Г.Б., Трофимов В.И. Бронхиальная астма. СПб.: Нордмед-Издат; 2006.

3. Федосеев Г.Б. Современные представления о причинах возникновения, особенностях течения и лечения бронхиальной астмы: Актовая речь. Л.; 1982.

4. Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma, updated 2010; www.ginasth*ma.org/pdf/GINA-Report-2010

5. Bel E.H. Clinical phenotypes of asthma. Curr .Opin. Pulm. Med. 2004; 10:44–50.

6. Bradding P., Green R.H. Subclinical phenotypes of asthma. Curr. Opin. Allergy Clin. Immunol. 2010; 10 (1): 54–59.

7. Nirav B.R., Prescott W.G. Human asthma phenotypes: from the clinic, to cytokines, and back again. Immunol. Rev. 2011; 242 (1): 220–232.

8. Минеев В.Н., Сорокина Л.Н., Берестовская В.С. и др. Содержание лептина в плазме крови при бронхиальной астме. Клин. мед. 2009; 7: 33–37.

9. Webster J.C., Oakley R.H., Jewell C.M. et al. Proinflammatory cytokines regulate human glucocorticoid receptor gene expression and lead to the accumulation of the dominant negative beta isoform: a mechanism for the generation of glucocorticoid resistance. Proc. Natl. Acad. Sci. USA 2001; 98: 6865–6870.

10. Минеев В.Н., Лалаева Т.М. Бронхиальная астма, ожирение и адипокины. Врач 2011; 4: 53–56.

11. Lugogo N.L., Kraft M., Dixon A.E. Does obesity produce a distinct asthma phenotype? J. Appl. Physiol. 2010; 108: 729–734.

12. Mosen D.M., Schatz M., Magid D.J., Camargo C.A. Jr. The relationship between obesity and asthma severity and control in adults. J. Allergy Clin. Immunol. 2008; 122: 507–511.

13. Eneli I.U., Skybo T., Camargo C.A. Jr. Weight loss and asthma: a systematic review. Thorax 2008; 63: 671–676.

14. Global Initiative for Asthma Global Strategy for Asthma Management and Prevention. Global Initiative for Asthma (GINA), updated 2010; http://www.ginasthma.org

15. Clinical Practice Guideline for the Management of Asthma in Children and Adults. VA/DoD clinical practice guideline for management of asthma in children and adults. Department of Veterans Affairs. Department of Defense. Version 2.0; 2009; http://www.healthquality.va.gov/asthma

16. Maniscalco M., Zedda A., Faraone S. et al. Weight loss and asthma control in severely obese asthmatic females. Respir. Med. 2008; 102 (1): 102–108.

17. Stenius*Aarniala B., Poussa T., Kvarnstrom J. et al. Immediate and long term effects of weight reduction in obese people with asthma: randomised controlled study. Br. Med. J. 2000; 320: 827–832.

18. Johnson J.B., Summer W., Cutler R.G. et al. Alternate day calorie restriction improves clinical ?ndings and reduces markers of oxidative stress and in?ammation in overweight adults with moderate asthma. Free Radic. Biol. Med. 2007; 42: 665–674.

19. Aaron S.D., Fergusson D., Dent R. et al. Effect of weight reduction on respiratory function and airway reactivity in obese women. Chest 2004; 125: 2046–2052.

20. Кокосов А.Н. (ред.). Разгрузочно-диетическая терапия: Руководство для врачей. СПб.: СпецЛит; 2007.

21. Peters*Golden M., Swern A., Bird S.S. et al. Influence of body mass index on the response to asthma controller agents. Eur. Respir. J. 2006; 27: 495–503.

22. Boulet L.P., Franssen E. Influence of obesity on response to fluticasone with or without salmeterol in moderate asthma. Respir. Med. 2007; 101: 2240–2247.

23. Sutherland E.R., Goleva E., Strand M. et al. Body mass and glucocorticoid response in asthma. Am. J. Respir. Crit. Care Med. 2008; 178: 682–687.

24. Dixon A.E., Shade D.M., Cohen R.I. et al. Effect of obesity on clinical presentation and response to treatment in asthma. Asthma 2006; 43: 553–558.

25. Holguin F., Bleecker E.R., Busse W.W. Obesity and asthma: An association modified by age of asthma onset. J. Allergy Clin. Immunol. 2011; 127: 1486–1493.

26. Friedenberg F.K., Xanthopoulos M., Foster G.D., Richter J.E. The association between gastroesophageal reflux disease and obesity. Am. J. Gastroenterol. 2008; 103: 2111–2122.

27. Bagnato G.F., Gulli S., Giacobbe O. et al. Bronchial hyperresponsiveness in subjects with gastroesophageal reflux. Respiration 2000; 67: 507–509.

28. Hancox R.J., Poulton R., Taylor D.R. et al. Associations between respiratory symptoms, lung function and gastrooesophageal reflux symptoms in a population-based birth cohort. Respir. Res. 2006; 7: 142.

29. Stein M.R. Possible mechanisms of influence of esophageal acid on airway hyperresponsiveness. Am. J. Med. 2003; 115 (Suppl. 3A): 55S–59S.

30. Kiljander T.O., Salomaa E.R., Hietanen E.K. et al. Gastroesophageal reflux and bronchial responsiveness: correlation and the effect of fundoplication. Respiration 2002; 69: 434–439.

31. Mastronarde J.G., Anthonisen N.R., Castro M. et al. Efficacy of esomeprazole for treatment of poorly controlled asthma. N. Engl. J. Med. 2009; 360: 1487–1499.

32. Julien J.Y., Martin J.G., Ernst P. et al. Prevalence of obstructive sleep apnea-hypopnea in severe versus moderate asthma. J. Allergy Clin. Immunol. 2009; 124: 371–376.

33. Straczkowski M., Dzienis*Straczkowska S., Stepien A. et al. Plasma interleukin-8 concentrations are increased in obese subjects and related to fat mass and tumor necrosis factor-α system. J. Clin. Endocrinol. 2002; 87: 4602–4606.

34. Kumada M., Kihara S., Ouchi N. et al. Adiponectin specifically increased tissue inhibitor of metalloproteinase-1 through interleukin-10 expression in human macrophages. Circulation 2004; 109: 2046–2049.

35. Wolf A.M., Wolf D., Rumpold H. et al. Adiponectin induces the anti-inflammatory cytokines IL-10 and IL-1RA in human leukocytes. Biochem. Biophys. Res. Commun. 2004; 323: 630–635.

36. Hotta K., Funahashi T., Bodkin N.L. et al. Circulating concentrations of the adipocyte protein adiponectin are decreased in parallel with reduced insulin sensitivity during the progression to type 2 diabetes in rhesus monkeys. Diabetes 2001; 50: 1126–1133.

37. Engeli S., Feldpausch M., Gorzelniak K. et al. Association between adiponectin and mediators of inflammation in obese women. Diabetes 2003; 52: 942–947.

38. Jung S.H., Park H.S., Kim K.S. et al. Effect of weight loss on some serum cytokines in human obesity: increase in IL-10 after weight loss. J. Nutr. Biochem. 2008; 19: 371–375.

39. Sood A., Cui X., Qualls C. et al. Association between asthma and serum adiponectin concentration in women. Thorax 2008; 63: 877–882.

40. Sood A., Ford E.S., Camargo C.A. Jr. Association between leptin and asthma in adults. Thorax 2006; 61: 300–305.

41. Bruno A., Pace E., Chanez P. et al. Leptin and leptin receptor expression in asthma. J. Allergy Clin. Immunol. 2009; 124: 230–237.

42. Loerbroks A., Apfelbacher C.J., Amelang M., Sturmer T. Obesity and adult asthma: potential effect modification by gender, but not by hay fever. Ann. Epidemiol. 2008; 18: 283–289.

43. von Mutius E., Schwartz J., Neas L.M. et al. Relation of body mass index to asthma and atopy in children: the National Health and Nutrition Examination Study III. Thorax 2001; 56:835–838.

44. Chen Y., Dales R., Jiang Y. The association between obesity and asthma is stronger in nonallergic than allergic adults. Chest 2006; 130: 890–895.

45. von Kries R., Hermann M., Grunert V.P., von Mutius E. Is obesity a risk factor for childhood asthma? Allergy 2001; 56: 318–322.

46. Kazaks A., Uriu*Adams J.Y., Stern J.S., Albertson T.E. No significant relationship between exhaled nitric oxide and body mass index in people with asthma. J. Allergy Clin. Immunol. 2005; 116: 929–930.

47. Sutherland T.J., Cowan J.O., Young S. et al. The association between obesity and asthma: interactions between systemic and airway inflammation. Am. J. Respir. Crit. Care Med. 2008; 178: 469–475.

48. van Veen I.H., Ten Brinke A., Sterk P.J. et al. Airway inflammation in obese and nonobese patients with difficult-totreat asthma. Allergy 2008; 63: 570–574.

49. Komakula S., Khatri S., Mermis J. et al. Body mass index is associated with reduced exhaled nitric oxide and higher exhaled 8-isoprostanes in asthmatics. Respir. Res. 2007; 8: 32.

50. Lessard A., Turcotte H., Cormier Y., Boulet L.*Ph. Obesity and asthma: a specific phenotype? Chest 2008; 134: 317–323.

51. Parameswaran K., Todd D.C., Soth M. Altered respiratory physiology in obesity. Can. Respir. J. 2006; 13: 203–210.

52. Boulet L.P, Turcotte H., Boulet G. et al. Deep inspiration avoidance and airway response to methacholine: influence of body mass index. Can. Respir. J. 2005; 12: 371–376.

53. Bustos P., Amigo H., Oyarzun M. et al. Is there a causal relation between obesity and asthma? Evidence from Chile. Int. J. Obes. (Lond) 2005; 29: 804–809.

54. Cottam D.R., Schaefer P.A., Shaftan G.W. et al. Effect of surgically-induced weight loss on leukocyte indicators of chronic inflammation in morbid obesity. Obes. Surg. 2002; 12: 335–342.

55. Esposito K., Pontillo A., Di Palo C. et al. Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. J.A.M.A. 2003; 289: 1799–1804.

56. van Huisstede A., Braunstahl G.J. Obesity and asthma: comorbidity or causal relationship? Monaldi Arch. Chest Dis. 2010; 73 (3): 116–123.

57. Hallstrand T.S., Fischer M.E., Wurfel M.M. et al. Genetic pleiotropy between asthma and obesity in a communitybased sample of twins. J. Allergy Clin. Immunol. 2005; 116: 1235–1241.

58. Pakhale S., Doucette S., Vandemheen K. et al. A comparison of obese and nonobese asthmatics: Exploring an asthmaobesity interaction. Chest 2010; 137: 1316–1323.

59. Aaron S.D., Vandemheen K.L., Boulet L.P. et al. Overdiagnosis of asthma in obese and nonobese adults. Can. Med. Assoc. J. 2008; 179: 1121–1131.


Для цитирования:


Минеев В.Н., Лалаева Т.М., Васильева Т.С., Трофимов В.И. Фенотип бронхиальной астмы с ожирением.  Пульмонология. 2012;(2):102-107. https://doi.org/10.18093/0869-0189-2012-0-2-102-107

For citation:


Mineev V.N., Lalaeva T.M., Vasilyeva T.S., Trofimov V.I. Phenotype of bronchial asthma with obesity. Russian Pulmonology. 2012;(2):102-107. (In Russ.) https://doi.org/10.18093/0869-0189-2012-0-2-102-107

Просмотров: 502


ISSN 0869-0189 (Print)
ISSN 2541-9617 (Online)